CONTIVUE Trademark

Trademark Overview

On Thursday, February 4, 2021, a trademark application was filed for CONTIVUE with the United States Patent and Trademark Office. The USPTO has given the CONTIVUE trademark a serial number of 90510073. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Wednesday, October 15, 2025. This trademark is owned by Genentech, Inc.. The CONTIVUE trademark is filed in the Medical Instrument Products category with the following description:

Ophthalmological apparatus and instruments, namely, implantable ocular drug delivery devices"
contivue

General Information

Serial Number90510073
Word MarkCONTIVUE
Filing DateThursday, February 4, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateWednesday, October 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2022

Trademark Statements

Goods and ServicesOphthalmological apparatus and instruments, namely, implantable ocular drug delivery devices"

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, May 7, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenentech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGenentech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, February 8, 2021NEW APPLICATION ENTERED
Monday, April 19, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 19, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 19, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 15, 2021ASSIGNED TO EXAMINER
Friday, July 16, 2021NON-FINAL ACTION WRITTEN
Friday, July 16, 2021NON-FINAL ACTION E-MAILED
Friday, July 16, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 11, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, August 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 28, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 28, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 29, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, January 27, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 20, 2022SOU TEAS EXTENSION RECEIVED
Thursday, October 20, 2022SOU EXTENSION 1 FILED
Thursday, October 20, 2022SOU EXTENSION 1 GRANTED
Saturday, October 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 24, 2023SOU TEAS EXTENSION RECEIVED
Monday, April 24, 2023SOU EXTENSION 2 FILED
Monday, April 24, 2023SOU EXTENSION 2 GRANTED
Wednesday, April 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 24, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, October 24, 2023SOU EXTENSION 3 FILED
Tuesday, October 24, 2023SOU EXTENSION 3 GRANTED
Monday, April 15, 2024SOU EXTENSION 4 GRANTED
Thursday, October 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 15, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 15, 2024SOU EXTENSION 4 FILED
Friday, May 3, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, May 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 16, 2024SOU EXTENSION 5 FILED
Monday, April 28, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 16, 2024SOU EXTENSION 5 GRANTED
Monday, April 28, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 28, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 28, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, October 15, 2025ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 15, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

contivue drug delivery devices ocular implantable apparatus instruments namely ophthalmological